Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
The Oncologist|February 10, 2017
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee ExperienceTodd C Knepper, Gillian C Bell, J Kevin Hicks, et al.
Annals of Hematology|December 1, 2017
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuationAndrew T Kuykendall, Savan Shah, Chetasi Talati, et al.
Cancer Medicine|December 22, 2020
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research ConsortiumRami S Komrokji, Najla H Al Ali, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Annals of Hematology|April 18, 2024
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CMLAkriti G Jain, Quinto Gesiotto, Somedeb Ball, et al.
Leukemia|July 31, 2020
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)Seongseok Yun, Susan M Geyer, Rami S Komrokji, et al.
Blood Neoplasia|October 2, 2025
A comparative assessment of molecular-based prognostic models in CMMLLuis E Aguirre, Najla Al Ali, Somedeb Ball, et al.
Leukemia Research|May 3, 2015
Impact of tobacco usage on disease outcome in myelodysplastic syndromesAsmita Mishra, Dana E Rollison, Thomas H Brandon, et al.
Leukemia Research|April 29, 2019
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)David A Sallman, Rami S Komrokji, Kendra L Sweet, et al.
Acta Haematologica|November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institutionDeniz Peker, Eric Padron, John M Bennett, et al.
Pageof 21